90 likes | 212 Views
NCATS Update Presentation for the CTSA Consortium Child Health Oversight Committee. Mary Purucker, MD, PhD NIH/NCATS CTSA Program Officer CC-CHOC Quarterly Webinar 30 January 2012. NCATS. The National Center for Advancing Translational Sciences Created 23 December 2011
E N D
NCATS Update Presentation for the CTSA Consortium Child Health Oversight Committee Mary Purucker, MD, PhD NIH/NCATS CTSA Program Officer CC-CHOC Quarterly Webinar 30 January 2012
NCATS The National Center for Advancing Translational Sciences Created 23 December 2011 Dissolution of NCRR Website: http://ncats.nih.gov/
NCATS Mission: The mission of the National Center for Advancing Translational Sciences is to catalyze the generation of innovative methods and technologies that will enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions
Components of NCATS • Clinical and Translational Science Awards • Office of Rare Diseases Research (OD/ORD) • Cures Acceleration Network ($10 M in new funding) • Therapeutics for Rare and Neglected Diseases (TRND) • Rapid Access to Interventional Development (RAID) • Molecular Libraries Program (intramural only) • FDA-NIH Regulatory Science
National CTSA Consortium – November 2011 WA ME MT ND VT MN OR NH ID WI NY SD MA MI RI WY CT IA PA NJ NE NV OH IN DE IL 60 CTSAs in 30 states and DC UT MD CO WV VA KS MO CA KY NC TN AR AZ OK SC NM GA AL MS TX LA AK FL HI PR = 2006–2011 CTSA Sites = CTSA States
NCATS Leadership • Dr. Thomas Insel is acting Director of NCATS • Also chairs the search committee for a permanent NCATS Director • Not an applicant • Continues as NIMH Director until permanent Director selected • Two Scientific Divisions: • Dr. Josie Briggs is acting Director of the Division of Clinical Innovation • Replaces Dr. Anthony Hayward, now Senior Advisor to the Director of NCATS • DCI is the new home to the CTSA program • Dr. Briggs will continue as NCCAM Director • Duration of appointment until permanent NCATS Director can appoint a new DCI Director • Dr. Chris Austin is Director of the Division of Preclinical Innovation • Former Director of National Center for Translational Technology (NHGRI-intramural) • TRND, RAID programs
NCATS Leadership • Four Offices: • Dr. Steven Groft is Director of the Office of Rare Disease Research • Dr. Jane Steinberg is acting Director of the Office of Grants Management • Will continue as OGM Director for NIMH • Duration of appointment until permanent NCATS Director selected • Erin Shannon is acting Director of the Executive Office of NCATS • Dr. Kathy Hudson is acting Director of the Office of Policy, Communication, and Strategic Alliances • Will continue as Deputy Director for Science Outreach and Policy in NIH OD • Duration of appointment until permanent NCATS Director selected • Policy Guidance and Leadership • NCATS Integration Committee • Thomas Insel, Josie Briggs, Eric Greene, Susan Shuren, Hugh Auchincloss, Walter Koroshetz, James Anderson
NCATS Priorities • Appoint permanent director • Timeline • Advisory Council • NARRC dissolved, interim will be NIDDK, date is February 15 • Release new RFA • To include new and competitive renewal CTSAs • Timeline is release by June 2012 • Submission date likely December 2012 • No plans to cut current elements/components of CTSAs • Allow each CTSA to focus on strengths
New CTSA Consortium Coordinating Center Started as of November 2011Website: www.ctsacentral.orgArchival CC-CHOC information available at: https://www.ctsacentral.org/committee/ctsa-consortium-child-health-oversight-committee Collaborative space rollout within the next several weeks CTSA Consortium Coordinating Center (C4)